Acute Lymphoblastic Leukemia: Challenges in MRD Testing

0 Views
administrator
administrator
08/04/23

Mark R. Litzow, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Ryan D. Cassaday, MD, reflect on challenges presented by minimal residual disease testing in acute lymphoblastic leukemia, such as lack of standardization, risk of oversensitivity, and constantly evolving data in this setting.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next